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Abstract
Tularemia or vaccination with the live vaccine strain (LVS) of Francisella tularensis confers long-lived cell-mediated immunity.
We hypothesized that this immunity depends on polyfunctional memory T cells, i.e., CD4
+ and/or CD8
+ T cells with the
capability to simultaneously express several functional markers. Multiparametric flow cytometry, measurement of secreted
cytokines, and analysis of lymphocyte proliferation were used to characterize in vitro recall responses of peripheral blood
mononuclear cells (PBMC) to killed F. tularensis antigens from the LVS or Schu S4 strains. PBMC responses were compared
between individuals who had contracted tularemia, had been vaccinated, or had not been exposed to F. tularensis (naı ¨ve).
Significant differences were detected between either of the immune donor groups and naı ¨ve individuals for secreted levels
of IL-5, IL-6, IL-10, IL-12, IL-13, IFN-c, MCP-1, and MIP-1b. Expression of IFN-c, MIP-1b, and CD107a by CD4
+CD45RO
+ or
CD8
+CD45RO
+ T cells correlated to antigen concentrations. In particular, IFN-c and MIP-1b strongly discriminated between
immune and naı ¨ve individuals. Only one cytokine, IL-6, discriminated between the two groups of immune individuals.
Notably, IL-2- or TNF-a-secretion was low. Our results identify functional signatures of T cells that may serve as correlates of
immunity and protection against F. tularensis.
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Introduction
There are two clinically important subspecies of Francisella
tularensis, subsp. holarctica and subsp. tularensis. Strains of the former
subspecies are found in many countries of the Northern
Hemisphere whereas the latter only occurs in North America.
Both are extremely infectious, and inhalation or intradermal
inoculation of as few as 10 CFU is sufficient to cause disease in
humans. A human live vaccine strain (LVS) of F. tularensis was
derived from a strain of F. tularensis subsp. holarctica and developed
in the United States during 1950s. It has been used in some
countries for vaccination of at-risk staff and also widely used in
experimental animal models.
Cell-mediated immunity (CMI) plays a crucial role in the host
defense against F. tularensis [1]. Both natural infection and
vaccination lead to long-lasting humoral and cell-mediated
immunity. The development of an effective host resistance is
paralleled by the appearance of F. tularensis-specific T cells [2,3,4].
Therefore, studies characterizing host CMI responses are
important for understanding the host immunity to tularemia
and, consequently, for the development of effective tularemia
vaccines. In humans, specific T cells appear earlier than antibodies
after the onset of disease or following vaccination with the live
vaccine strain (LVS), and remain detectable for several decades
thereafter [5]. As early as two weeks after vaccination, a majority
of immunized volunteers exhibit an F. tularensis-specific prolifer-
ative response [6]. The T-cell responses after natural infection or
vaccination in humans persist for at least 25 years, whereas levels
of F. tularensis-specific antibodies are virtually undetectable two to
three decades after primary infection or vaccination [4,7]. Both
CD4
+ and CD8
+ T cells from individuals with a history of
tularemia show proliferative responses and IFN-c production to
various membrane proteins of the pathogen [8,9]. The relative
CD4
+ and CD8
+ T-cell responses were found to be equally potent
[8]. This conforms well with recent studies in mice that have
established the importance of both LVS vaccination-induced
CD4
+ and CD8
+ T cells as well as of IFN-c in protection against
systemic and aerosol infection with F. tularensis subsp. tularensis
strains [10,11]. These studies reaffirmed the notion that CMI is
the critical determinant of F. tularensis immunity. Although IFN-c
production upon recall stimulation is a hallmark of F. tularensis
immunity, it is not clear which subsets of cells are responsible for
generating this cytokine and if the cytokine is necessary for effector
cells. Moreover, although IFN-c is necessary for protection in
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not survive infection with F. tularensis subsp. tularensis still produce
high levels of this cytokine [12].
Often T-cell responses have been characterized as the frequency
of antigen-specific T cells and/or the expression of a specific
effector function. However, this may be insufficient to describe
their full potential. Therefore, other more multifaceted descrip-
tions have been used recently to better describe the complexity of
T-cell responses. One technique that allows more complex
analyses of T-cell functions is multi-parameter flow cytometry
that can characterize multiple functions with regard to magnitude,
phenotype, and functional capacity. A number of recent studies
have elucidated cell-mediated immune responses as immune
correlates of protection subsequent to various infections or after
vaccination [13,14]. Collectively, the results demonstrate that the
multifaceted descriptions of T-cell phenotypes show good
correlation to protection and help to explain why certain
functional populations of cytokine-producing T cells are critical
to the host defense against infectious pathogens. Based on several
models of infectious diseases, it has been suggested that
proliferation of polyfunctional CD4
+ or CD8
+ T cells and their
production of IFN-c and IL-2 are crucial parameters to define
protection [15]. One notable finding was that polyfunctional
CD4
+ T cells secreting IFN-c, TNF-a, and IL-2 were found to
constitute an important component of human and murine
immune responses to Leishmania and the presence of the cell
subset correlated with protection in mice [16]. However, a number
of recent studies on tuberculosis have come to somewhat
contradictory conclusions regarding the relevance of polyfunc-
tional T cells [17]. Thus, much remains to be clarified about the
significance of such T cells. There are no published reports
describing the induction of polyfunctional T cells after LVS
vaccination or after infection with F. tularensis in either animal
models or humans.
Our aim was to characterize F. tularensis-specific PBMC in
individuals who had had tularemia or who had been vaccinated
with LVS by determining proliferative responses and secreted
cytokine profiles of PBMC upon re-stimulation with F. tularensis
antigens. Our aim was to identify features of the T-cell responses
present in immune individuals that may serve as correlates of
immunity, i.e., correlates that uniformly characterize the F.
tularensis-specific immune response.
Results
Statistical evaluation of effects of age, gender, and
duration after onset of disease on recall stimulation
responses
We characterized F. tularensis-specific human T cells that
responded during recall stimulation. For this purpose we collected
PBMC samples from donors who were either convalescent
tularemia patients, had been vaccinated with LVS, or were naive
individuals. We analyzed PBMC responses to recall stimulation
with killed F. tularensis antigens (ffLVS or ffSchu S4) by measuring
their proliferative capacity, cytokine secretion, and the presence of
polyfunctional T cells within the PBMC population. All samples
were characterized by all three methods to achieve co-linear data.
The data were analyzed by pair-wise comparisons of the results
from each donor group; naı ¨ve donors vs. vaccinees (nv/vc), naı ¨ve
donors vs. patients (nv/p), and vaccinees vs. patients (vc/p). In
addition to data from recall stimulation with specific antigen
concentrations, we also compared the increases in the responses
between each antigen concentration as an indicator of the antigen
specificity of the measured immune response.
By use of Spearman’s correlation test, we analyzed if the
reactivity as measured by each of the three methods was affected
by the age of the individuals, or by the duration between onset of
tularemia and time of blood sampling. However, no significant
correlations were found, indicating that the measured immune
responses are quantitatively and qualitatively long-lived. In
addition, we tested differences for all parameters between male
and female patients using Wilcoxon’s rank-sum test, but no
significant differences were found.
Responses to a mitogen, ConA, were very similar (Spearman’s
correlation P.0.60 for all pair-wise comparisons) between the two
groups of immune individuals and naı ¨ve individuals (naı ¨ve:
27,900 cpm616,000; patients: 32,700 cpm631,800; vaccinees:
36,200 cpm621,900, n=8 for each group), indicating that there
were no inherent differences with regard to the T-cell reactivity of
each of the groups.
Proliferative responses to F. tularensis antigens
Proliferative responses after recall stimulation of PBMC from
immune donors, patients or vaccinees increased with increasing
antigen concentrations and were significantly higher than those of
cells from naı ¨ve individuals (Fig. 1, Table S1). PBMC samples
from the majority of the immune donors were maximally induced
by the medium antigen concentration of 0.1 cfu ffLVS/PBMC
and no significant differences were observed between the two
highest antigen concentrations for any of the donor groups. In
addition, we did not find any significant differences between the
two groups of immune donors for any antigen concentration or
antigen-dependent increase (Table S1). The proliferative re-
sponses to the ffSCHU S4 were somewhat lower than those to the
ffLVS antigen, but these differences were not statistically
significant (not shown). In fact, the responses to the two antigens
were correlated with a highly significant Spearman’s correlation
coefficient of .0.7.
Cytokine Secretion upon Recall Stimulation
Previously, we found that PBMC from LVS vaccinated
individuals secreted higher amounts of 11 cytokines in response
to recall stimulation with ffLVS than did PBMC from naı ¨ve
individuals, although only IL-5, IL-10, IFN-c, and MIP-1b were
significantly higher [7]. Most of these cytokines had also been
Figure 1. Stimulation indices for the proliferative responses of
human PBMC to recall stimulation with ffLVS for five days.
Median values 6 SEM per donor group of 12–16 individuals are shown.
‘‘pat’’ indicates convalescent tularemia patients, ‘‘vc’’ LVS vaccinees, and
‘‘nv’’ naı ¨ve individuals.
doi:10.1371/journal.pone.0032367.g001
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mouse model [18]. Therefore, we analyzed secretion of the same
cytokines. Statistically significant differences between either of the
immune donor groups and naı ¨ve individuals were consistently
detected for eight out of the eleven cytokines, i.e., IL-5, IL-6, IL-
10, IL-12, IL-13, IFN-c, MCP-1, and MIP-1b, and their secretion
increased with increasing antigen concentrations (Figs. 2 and 3,
Table S2). Surprisingly, this was not true for IL-2 and only partly
true for TNF-a. Only IL-6 differed between the two groups of
immune donors. Curiously, in the absence of antigen, there were
somewhat higher levels of MIP-1b in PBMC cultures from
immune donors than in those from naı ¨ve donors.
Cytokine levels were also determined using the ffSchu S4
antigen and they were lower compared to cultures stimulated with
ffLVS, although the differences were not significant (Figs. 2 and
3). These discriminating cytokines were IL-5, IL-6, IFN-c, MCP-
1, MIP-1b, IL-10, IL-12 and IL-13. Again, the responses to the
two antigens were highly correlated with a Spearman’s correlation
coefficient of .0.7.
Thus, a majority of the tested cytokines discriminated between
the responses of the immune versus the naı ¨ve individuals.
However, only one cytokine discriminated between vaccinees
and patients, indicating that the priming of the immune response
after vaccination with LVS closely mimics that after natural
infection with subspecies holarctica.
Identification of antigen-specific polyfunctional T cells
To identify polyfunctional F. tularensis-specific T cells, i.e., cells
that produce several effector cytokines or chemokines simulta-
neously, we used polychromatic flow cytometry of PBMC that had
been restimulated with F. tularensis antigen for 48 h. Memory T
cells were identified as CD3
+CD4
+CD45RO
+ or CD3
+CD8
+
CD45RO
+ cells, and cytokine production was detected by
intracellular cytokine staining. CD45RO is a marker of memory
T cells in humans [19]. IFN-c has long been recognized as a key
characteristic of the F. tularensis-specific immune response
[8,20,21]. Accordingly, we found that essentially all of the IFN-c
expressing T cells also were CD45RO
+ (data not shown). We
detected IL-2-producing cells in the CD4
+ and the CD8
+ T-cell
populations of PBMC from vaccinees upon recall stimulation, but
their numbers differed significantly (P,0.05) from those of non-
stimulated control samples from the same donor only in the CD8
+
subset (Fig. S1). The low number of cells expressing intracellular
IL-2 at 48 h after recall stimulation likely reflected the regulation
and turnover of IL-2 in response to antigen; we found IL-2-
expressing cells also after other stimulation periods (24, 72 and
96 h), but their numbers did not correlate with antigen
concentrations (not shown). For TNF-a, a small population could
be identified (Fig. S1). However, similar to our observation for IL-
2, there was no increase in the TNF-a
+ cell populations with
increasing antigen concentrations at any of the time points tested.
Hence, for the recall response of human peripheral blood T cells
to ffLVS, the intracellular expression of IL-2 and TNF-a appeared
to be of minor importance and this was in agreement with the low
levels of secreted IL-2 and TNF-a (Figs. 2 and 3).
We then analyzed IFN-c
+ CD45RO
+ cell populations for co-
expression of MIP-1b, CD107a and/or CD127. The surface
marker CD127 (also known as IL-7Ra) has also been examined in
several studies characterizing memory T cells [22,23] but its
expression did not increase in an antigen-dependent fashion (data
not shown). MIP-1b (macrophage inflammatory protein-1b),
CCL4 is a marker of recall responses in studies on tuberculosis
patients and represents a type of polyfunctional T cell [24,25]. We
identified MIP-1b as one of the secreted cytokines in response to
ffLVS (Fig. 3). Studies on vaccine-induced polyfunctional T cells
showed that surface-relocated intracellular CD107a (also known as
LAMP-1) together with granzyme B and perforin could be used as
indicators of the cytotoxic capacity of CD8
+ T cells [26,27]. The
Figure 2. Levels of cytokines secreted by human PBMC after recall stimulation with ffLVS or ffSchu S4 for five days. Cytokine
concentrations were measured in cell culture supernatants using multiplex analysis. Median values 6 SEM from PBMC samples of 14–16 individuals
per donor group are shown (black bars indicate convalescent patients; grey bars indicate LVS vaccinees; white bars indicate naı ¨ve donors).
Statistically significant differences between immune and naı ¨ve donors are marked by asterisks (P,0.05). For IL-7, 36 out of 40 values were below the
detection limit and therefore not included in the data analysis.
doi:10.1371/journal.pone.0032367.g002
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+, CD4
+, or CD8
+ T cells expressing at
least one marker, i.e. IFN-c, MIP-1b, or CD107a, increased with
higher antigen concentrations (Figs. 4, 5, 6). This increase was
more pronounced in PBMC samples from immune individuals
than from naı ¨ve donors (Figs. 5 and 6 vs. Fig. 4). Moreover,
among the 150,000 events recorded per PBMC sample, we
reproducibly identified small groups of polyfunctional CD4
+ or
CD8
+ T cells in immune individuals that simultaneously expressed
two or three of the intracellular markers. We also identified
CD45RA
+ T cells, predominantly a marker of naı ¨ve T cells [19].
However, there exist short-lived effector cells that also express the
marker CD45RA [28]. CD45RA
+ T cells that expressed one, two,
or three functional markers were relatively rare and frequencies
were generally lower than those of CD45RO
+ T cells (Figs. 4, 5,
6). In both cell subsets, frequencies of the polyfunctional
populations showed a similar antigen-dependent increase. Thus,
polyfunctional T cells appeared to be part of the recall response to
the F. tularensis antigen.
Median fluorescence intensity (MFI) is a measure of the
expression level of a given surface or intracellular marker in a
cell population. Recently, the integrated MFI (iMFI) was
introduced as a measure that in addition to cell marker expression
levels takes into account the frequency of cells expressing a given
marker [16]. The iMFI is calculated by multiplying the frequency
of positive cells by the MFI of a given marker. Statistical analysis of
iMFI data following restimulation with 0.1 cfu ffLVS/PBMC
demonstrated no significant differences between the two groups of
immune individuals, while most iMFI values (78 of 96 tests) from
the immune donors differed significantly from those of naı ¨ve
donors (Fig. 7). It is noteworthy that almost all of the non-
significant P values were related to CD107a-expressing T-cell
subsets. Similar observations were made with respect to antigen-
dependent increases; we found significantly higher increases of
iMFI with increasing antigen concentrations for most of the 24
variables, 208 of 288 comparisons, from the two groups of immune
individuals as compared to iMFI data from naı ¨ve donors, while we
did not detect any such differences between vaccinees and patients
(Fig. 7). Again, we noted that most of the non-significant P values
(65 of 80 tests) originated from the iMFI of CD107a or from the
iMFI of IFN-c or MIP-1b in a CD107a
+ T-cell population.
Collectively, IFN-c and MIP-1b were very useful to discriminate
between the responses of F. tularensis-immune and naı ¨ve individ-
uals, whereas CD107a
+ expression, although it increased in an
antigen-dependent fashion, appeared to be less related to the
Francisella-specific recall responses.
We also compared the iMFI values after stimulation with ffLVS
or ffSCHU S4. iMFI values were higher after ffLVS than after
ffSCHU S4 stimulation, nevertheless, the responses were very
highly correlated (not shown).
Apart from the classical CD4
+ and CD8
+ single positive T cells,
we identified a high percentage of CD3
+CD4
2CD8
2 cells in
antigen restimulated cultures for all three donor groups (17–29%
of CD3 T cells), but only small percentages of CD4
+CD8
+ cells
(,1% of CD3
+ T cells). Such CD4
+CD8
+ double positive cells are
increased in autoimmune disorders [29] and they produce
cytokines like TNF-a, IFN-c, or MIP-1b upon restimulation
[30]. Although few, the frequencies of CD4
+CD8
+ T cells in recall
stimulated PBMC from immune donors correlated to the
concentration of recall antigen and so did a distinct subset that
expressed IFN-c (Figs. S2A and S2B). Similar observations were
made for CD107a- and for MIP-1b-expressing CD4
+CD8
+ cells
(Figs. S2C and S2D).
Determining Correlates of Immunity
To identify correlates of immunity that can be evaluated in
animal models of tularemia, we analyzed our collected data for
Figure 3. Levels of cytokines secreted by human PBMC after recall stimulation with ffLVS or ffSchu S4 for five days. Cytokine
concentrations were measured in cell culture supernatants using multiplex analysis. Median values 6 SEM from PBMC samples of 14–16 individuals
per donor group are shown (black bars indicate convalescent patients; grey bars indicate LVS vaccinees; white bars indicate naı ¨ve donors).
Statistically significant differences between immune and naı ¨ve donors are marked by asterisks (P,0.05).
doi:10.1371/journal.pone.0032367.g003
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immune and naı ¨ve individuals (dimensional reduction). Hierar-
chical cluster analysis of the iMFI data for mono- and bifunctional
subsets of CD3
+CD4
+ and CD3
+CD8
+ T cells showed good
separation of PBMC samples from naı ¨ve individuals from those of
immune donors, since eight out of ten samples from naı ¨ve
individuals clustered to one branch of the dendrogram (Fig. S3).
Samples from predominantly vaccinees and patients formed
another major branch in the middle and the left-most branch
contained only samples from vaccinees and patients.
Problems with near co-linearity can arise in strict multivariate
models with too many variables, i.e. strongly correlated variables
contribute essentially the same information multiple times.
Therefore, we asked whether some of the data could be
disregarded without losing too much information. For each donor
we compared the iMFI values of all three functional markers in all
mono-, bi- and trifunctional T-cell subsets with each other and
tested for correlation. Overall, iMFI values of IFN-c and MIP-1b
within the same polyfunctional T-cell subset were highly
correlated (Fig. 8). Monofunctional IFN-c2 or MIP-1b-express-
ing CD4
+ and CD8
+ T cells were highly correlated while this was
not true for CD107a-expressing T cells. In fact, the CD107a
+ cells
were remarkably uncorrelated with the iMFI of other markers
(Fig. 8). Since most polyfunctional cell subsets were gated based
on their IFN-c expression, the IFN-c
+ monofunctional T-cell
subsets were highly correlated with a large number of bi- and
trifunctional cells. Data for MIP-1b also showed this pattern, yet to
a lesser degree. For the bi- and trifunctional cell subsets, most
iMFI groups were strongly correlated to at least a few other
groups. These observations suggest that it might be possible to
select iMFI variables of a few cell subsets that contain essentially
the same information as the complete data set, e.g. MIP-1b of the
CD4
+ IFN-c
+ MIP-1b
+ subset was strongly correlated with almost
all other variables and can be considered a good candidate for
further modeling.
Most parameters measured from our three experimental
methods, LPA, secreted cytokine analysis, and flow cytometry,
each provided very good discrimination between immune and
naı ¨ve individuals. The following features of human PBMC can
therefore be considered correlates of immunity against F. tularensis:
i) lymphocyte proliferation; ii) secretion of IL-5, IL-6, IL-10, IL-12,
IL-13, IFN-c, MCP-1 and MIP-1b; iii) IFN-c and MIP-1b
expression by CD4
+ CD45RO
+ or CD8
+CD45RO
+ T cells. We
asked how well these parameters predicted the immune status of a
donor and whether any combination of parameters improved the
predictive power. We used logistic modeling to investigate the
multivariate relations between readouts from the three experi-
mental methods. We based the modeling calculations on LPA,
Figure 4. Histograms indicating the frequency of mono-, bi- and tri-functional cell subsets in CD45RO
+ and CD45RA
+ T-cell
populations of non-vaccinated individuals. Mean values are illustrated throughout. The black axis indicates percentages for mono-functional
IFN-c-positive and all bi- and tri-functional T-cell subsets. The red axis indicates percentages for MIP-1b- and CD107a-positive mono-functional T cell
subsets.
doi:10.1371/journal.pone.0032367.g004
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ffLVS/PBMC, with the aim to build models that with the smallest
number of features and the highest accuracy correctly predict the
immune status of a donor. We included the above listed correlates,
but also those parameters that did not show significant differences
between naı ¨ve and immune donors, e.g. secreted levels of TNF-a in
order to investigate whether the latter parameters could
nevertheless contribute to increased predictive power. The models
with the highest predictive power as measured by cross-validation
were selected. Models with only one parameter, e.g., LPA or
secreted IL-13, IFN-c, IL-5 or MIP-1b, correctly identified the
immune status of 90–97% of the individuals (Table 1). Flow
cytometry data alone did not reach such accuracy, but could in
combination with other data on secreted cytokines form highly
accurate models. In addition, there were other combinations of
two or three parameter-based models that performed as well as
those listed. We also modeled the same parameters to distinguish
between convalescent patients and LVS vaccinees, however, no
clear pattern of separation could be found (not shown).
Thus, individual immune parameters, or combinations thereof,
predicted with high accuracy the immune status of the individuals,
however, they did not discriminate between the two groups of
immune donors, indicating that the immune responses of these
groups are very similar and may be functionally inseparable.
Discussion
Multi-parameter flow cytometry has been implemented recently
to characterize memory T cells, and this technique has enabled
detailed descriptions of the cells’ phenotypic characteristics and
functional abilities. Generally, it has been argued that certain
polyfunctional T cells show good correlation with improved host
control of infectious disease. In several experimental models it has
been found that simultaneous production of IFN-c, TNF-a, and
IL-2 by CD4
+ or CD8
+ T cells is crucial to protection. Recent
studies of a recombinant tuberculosis vaccine based on Ag85A
demonstrated that such trifunctional cells dominated the immune
response [15,16,31]. In addition, a study on tuberculosis patients
revealed higher numbers of such trifunctional CD4
+ T cells in the
patients compared to their exposed, but asymptomatic household
contacts [32]. In contrast, another study found that cells expressing
IFN-c, TNF-a, and IL-2 were present in almost all patients with
active disease, but in less than 15% of those donors with latent
disease [17]. Instead, in patients with latent disease higher
numbers of bifunctional T cells (IFN-c
+IL-2
+) were found [17].
Moreover, studies of HIV and other chronic viral infections have
associated trifunctional CD4
+ and/or CD8
+ T cells with non-
disease progression [33,34]. Thus, although certain types of
polyfunctional T cells play important roles as correlates of
Figure 5. Histograms indicating the frequency of mono-, bi- and tri-functional cell subsets in CD45RO
+ and CD45RA
+ T-cell
populations of vaccinees. Mean values are illustrated throughout. The black axis indicates percentages for mono-functional IFN-c-positive and all
bi- and tri-functional T-cell subsets. The red axis indicates percentages for MIP-1b- and CD107a-positive mono-functional T cell subsets.
doi:10.1371/journal.pone.0032367.g005
Correlates of Immunity to Francisella tularensis
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32367immunity, there is no clear consensus for various diseases or for
different modes of disease and more research is warranted in order
to obtain a comprehensive picture.
Our results demonstrate that the immune responses of F.
tularensis-immune individuals are quite distinct from those reported
for tuberculosis or HIV patients. Although a previous study
identified the presence of IL-2, IL-2R, and TNF-
+as markers of
the recall response against F. tularensis (12), we did not observe
significant F. tularensis specific production of either IL-2 or TNF-a.
It has been proposed that the phenotypes of identified memory T
cells could be affected by the in vitro conditions utilized and that
assays carried out for only 24 h would identify only recently
primed cells, but not memory T cells in the resting state [35]. It
has also been hypothesized that the latter cell population might be
detectable only after prolonged incubation, for example six days
[17,35]. Our protocol was based on the incubation of T cells for
48 h before flow cytometry analysis, and secreted cytokines were
measured after five days of culture. Thus, our analyses were not
based on very prolonged recall stimulation, but covered two
different incubation periods. Moreover, in preliminary flow
cytometry analyses we included incubation periods up to 96 h,
but still did not detect any antigen-dependent increase in IL-2 or
TNF-a.We believe that the length of the incubation period is an
unlikely explanation for the lack of detection of IL-2, since it
should precede the proliferation of the cells. It appears as if the IL-
2 secreted by the T cells is minimal in this model, or has a very fast
turnover. Therefore, we conclude that although we detected
polyfunctional T cells after stimulation with F. tularensis antigen,
these cells did not demonstrate polyfunctionality with regard to IL-
2 or TNF-a, but instead produced IFN-c, MIP-1b, and CD107a.
The importance of IFN-c as an indicator of immunity against F.
tularensis is well-documented [1] and IFN-c secretion alone
predicted the F. tularensis immune status with high accuracy. We
here demonstrated that the majority of the IFN-c producing T
cells from peripheral blood are memory T cells as characterized by
expression of CD45RO. This is in agreement with findings in our
previous publication that characterized immune responses in
vaccines [7]. In addition to the previous findings, we here
demonstrate that the IFN-c expressing cell population also
displayed additional functions, i.e., expression of MIP-1b and/or
CD107a, thereby showing polyfunctionality. CD107a expression
was low in general, but showed an antigen-dependent increase in
immune individuals. However, in several statistical comparisons
we found that CD107a expression by T cells did not differentiate
between immune and naı ¨ve subjects. CD107a was also less well, or
not at all, correlated with expression of the other two intracellular
Figure 6. Histograms indicating the frequency of mono-, bi- and tri-functional cell subsets in CD45RO
+ and CD45RA
+ T-cell
populations of convalescent patients. Mean values are illustrated throughout. The black axis indicates percentages for mono-functional IFN-c-
positive and all bi- and tri-functional T-cell subsets. The red axis indicates percentages for MIP-1b- and CD107a-positive mono-functional T cell
subsets.
doi:10.1371/journal.pone.0032367.g006
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other. It is at present not clear whether there is biological
significance in the observations regarding CD107a.
IFN-c and MIP-1b were also secreted in high amounts and
clearly discriminated between responses of immune vs. naı ¨ve
individuals. Together with the flow cytometry results, this implies
that IFN-c and MIP-1b are produced by F. tularensis-specific T
cells as a result of recall stimulation. MIP-1b production was a
parameter recurring in the mathematical models with high
prediction accuracy. MIP-1b
+ polyfunctional T cells have also
been detected in other models of infectious diseases. For example,
a tuberculosis vaccine based on modified vaccinia virus Ankara
expressing antigen 85A, and the Yellow Fever vaccine induced T
cells producing combinations of IFN-c, TNF-a, IL-2, and MIP-1b
[24,36]. In addition, Freel et al. demonstrated correlation between
the combined expression of CD107a and MIP-1b by CD8
+ T cells
and anti-HIV-1 activity using a virus inhibition assay [37]. The
mechanism whereby MIP-1b confers a protective effect has not
been directly studied in conjunction with its proven role in the
polyfunctional immune responses, however, in the case of viruses
dependent on CCR5, it may act by blocking the receptor. Its role
for control of bacterial infection is more elusive and a direct
effector function has not been proven. However, it plays an
important role for recruitment of monocytes in vitro and in vivo and
thereby may contribute significantly to the protection in
conjunction with other direct effectors, such as IFN-c [38].
In agreement with the present results on the F. tularensis-specific
T cells, expression of CD107a, IFN-c, and MIP-1b therefore
appears to be a rather ubiquitous feature of protective immune
responses. Furthermore, logistic modeling revealed that several
other parameters, i.e. the LPA test or secreted IL-13, MCP-1, IL-5
or IL-6, alone correctly identify the F. tularensis-specific immune
status of .91% of the individuals. Thus, these parameters appear
to be indicators of immunity to F. tularensis and further work will
validate their utility as correlates of protection for vaccine licensing
through the FDA’s Animal Rule.
Our analyses of the PBMC responses demonstrated clear
discrimination between the two groups of immune donors versus
Figure 7. Probability values for comparisons of iMFI data for intracellular markers in various T-cell subsets after recall stimulation.
Integrated MFI values were obtained for all three functional markers (IFN-c, MIP-1b, CD107a) in all mono-, bi- and trifunctional T-cell subsets (24
values per PBMC sample) and for all donors using Clust semi-automated gating. Median iMFI values after stimulation with 0.1 cfu ffLVS/PBMC or the
median antigen-dependent increases of the iMFI were analyzed for statistically significant differences between donor groups (5–10 naı ¨ve individuals
[nv], 8–12 vaccinees [vc], 8–12 patients [pat]). Symbols indicate P values.
doi:10.1371/journal.pone.0032367.g007
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was an antigen-dependent increase of the PBMC responses from
immune donors. Notably, for the majority of the results generated
with the three methods, there were very few differences between
vaccinees and convalescent patients. Altogether, our results
strongly suggest that the immune responses of vaccinated
individuals and patients are quantitatively and qualitatively more
or less identical. Additionally, no significant differences were found
between the ffLVS and ffSCHU S4 antigens. Thus, although the
vaccine is a live subsp. holarctica strain, the ensuing immune
response after vaccination closely resembles that after natural
infection with subspecies holarctica and responses are equal to
antigens from subspecies holarctica and tularensis strains [39]. With
regard to the persistence of immunity upon vaccination, we
recently performed an extensive analysis of CMI responses in long-
term (.27 years) and short-term (,3 years) vaccinees and found
that both donor groups exhibited essentially identical lymphocyte
proliferation and secreted cytokine patterns in response to ffLVS
[7]. This longevity of the T-cell memory to F. tularensis after
vaccination is comparable to what has been found 25 years after
tularemia [4]. Our results therefore indicate that vaccination with
LVS may lead to essentially lifelong persistence of F. tularensis-
specific T-cell immunity.
Collectively, our analyses demonstrate that LPA together with
MIP-1b, IFN-c, IL-5, and IL-10 secretion showed very high
discriminatory power between naı ¨ve and immune donors. The
flow cytometry analysis revealed that the responses of immune
individuals were characterized by higher expression of MIP-1b
and IFN-c and this was true for all cell subsets. Therefore, all of
these parameters are correlates of immunity and may be relevant
as potential correlates of protection as well. For ethical reasons it is
unlikely that challenge studies with virulent strains will be
performed in humans to assess vaccine efficacy. We therefore
Figure 8. Heat map of Spearman correlation coefficients for iMFI values in various cell populations after intra-individual
comparison for all donors. Integrated MFI values were obtained for all three functional markers (IFN-c, MIP-1b, CD107a) in all mono-, bi- and
trifunctional T-cell subsets and for all donors using Clust semi-automated gating. The iMFI values (24 values per PBMC sample, identified by numbers
1–24) from recall stimulation with 0.1 cfu ffLVS/PBMC were compared and lined up in a two-dimensional matrix. Correlated data are marked by
shades of grey depending on the strength of the correlation coefficients; a coefficient above 0.7 is considered to indicate very strong correlation.
doi:10.1371/journal.pone.0032367.g008
Table 1. Correlates of immunity against F. tularensis as
suggested by the accuracy of prediction models.
Parameter analyzed
a) Cross-validation
b)
IL-13 (Secreted) 0.969
MCP-1 (Secreted)+TNF-a (Secreted) 0.969
IFN-c (Secreted) 0.938
LPA 0.925
IL-5 (Secreted) 0.913
IL-6 (Secreted)6MIP-1b iMFI in CD8
+MIP-1b
+ 0.907
MIP-1b (Secreted) 0.901
a)See Materials & Methods for a description of the prediction models.
Interaction terms ‘‘x’’ and ‘‘+’’ connecting two parameters indicate synergistic
and additive interactions, respectively.
b)A cross validation value .0.9 indicates that more than 90% of individuals will
be correctly identified as immune donors.
doi:10.1371/journal.pone.0032367.t001
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parameters as correlates of protection since the FDA’s Animal
Rule allows for licensing of vaccines against rare but lethal
pathogens by use of relevant animal models for efficacy testing.
Materials and Methods
Ethics Statement
Ethical approval, 05–166 M, was obtained from the Regional
Ethical Review Board in Umea ˚, Sweden, and a written informed
consent was obtained from all individuals included in the study.
Blood Donors
Individuals included in the study had either previously been
diagnosed with tularemia caused by F. tularensis subsp. holarctica
(convalescent patients, p), been vaccinated with LVS (vaccinees,
vc), or had no anamnestic data on LVS vaccination, tularemia, or
occupational exposure to F. tularensis (naı ¨ve, nv). Convalescent
patients had contracted tularemia in Sweden one to 32 months
before blood donation (mean time 16.1610.6 months). All
vaccinees had been given the same lot of LVS, designated NDBR
101, lot no. 11. The mean age and sex distribution of each group
was the following: naı ¨ve individuals 36.5 years (10 females, 5
males), vaccinees 44.5 years (10 females, 7 males), and convales-
cent patients 53.4 years (6 females, 10 males). A detailed
description is provided in Table S3.
PBMC Collection and Cryopreservation
Venous blood from donors was collected using CPT-tubes
(Becton Dickinson, NJ, USA) and PBMC were prepared according
to the manufacturer’s recommendations. PBMC samples were
cryopreserved as follows: the cells were resuspended in freezing
medium (80% heat-inactivated human serum [Innovative Re-
search, MI, USA], 20% dimethyl sulfoxide) at a concentration of
10
7 PBMC/mL. Cells were aliquoted into 1 mL cryo-vials, and
transferred to long term storage in liquid nitrogen using a
NALGENE cryo 1uC Freezing Container. To thaw PBMC
samples, selected aliquots were quickly thawed at 37uC and
diluted, first in washing media (10% heat-inactivated fetal calf
serum, 40 m/mL of gentamicin in RPMI 1640 medium [GIBCO/
Invitrogen]), then in culture medium (10% heat-inactivated
human serum, 40 mg/mL gentamicin in RPMI 1640 medium).
Cells were allowed to recover overnight; cell viability and the cell
recovery rate were determined prior to downstream functional
assays.
Recall Stimulation and Lymphocyte Proliferation Assay
(LPA)
For LPA and multiplex cytokine analysis, PBMC were seeded at
2610
5 cells/well in 100 mL culture medium per well in 96-well
plates. For each flow cytometry analysis, four wells of a 96-well
plate with 4610
5 cells per well were used. Cells were stimulated
with formalin-fixed LVS (ffLVS) or Schu S4 antigen at final
concentrations of 0.02, 0.1, or 0.5 cfu/PBMC or without antigen
and incubated for two (flow cytometry) or five days (LPA and
multiplex cytokine analysis) at 37uC in a humidified atmosphere
with 5% CO2. We used the mitogens Concanavalin A and
Phytohemagglutinin as control antigens. LPA was performed by
thymidine incorporation in triplicates as previously described [4].
The mean of each triplicate for each antigen concentration was
normalized by dividing it by the corresponding value for non-
stimulated control cultures from the same PBMC sample to obtain
a stimulation index.
Multiplex Cytokine Analysis
Cell culture supernatants, 80 mL, were collected from the same
cell cultures as used for LPA and stored frozen at 280uC until
analyzed using two custom-made multiplex kits and a Bio-Plex 200
system (BioRad Laboratories Inc, Hercules, CA, USA) according
to the manufacturer’s instructions. A 5-plex kit and 30-fold diluted
supernatants were used to determine the levels of MIP-1b, MCP-
1, IL-6, IFN-c and TNF-a (high level cytokines), and a 6-plex kit
in combination with two-fold diluted supernatants were used to
measure IL-2, IL-5, IL-7, IL-10, IL-12(p70) and IL-13 (low level
cytokines). Estimated cytokine concentrations outside the range of
the standard curve were censored to the nearest standard value.
Samples were analyzed in duplicate.
Flow cytometry analysis of surface markers and
intracellular cytokine staining
After 44 h of recall stimulation, 5 mg/mL of Brefeldin A was
added to the PBMC cultures. Four h later, plates were centrifuged
for 3 min at 5006g and supernatants were removed. Cells were
prepared for labeling with cell surface marker monoclonal
antibodies (mAb) or conjugated intracellular cytokine mAb as
recommended by BD Biosciences. The following mAb conjugates
were used: CD3-AlexaFluor700 (clone UCHT1, BD Biosciences),
CD4-PE Texas red (clone S3.5, Caltag/Invitrogen), CD8-
PerCPCy5.5 (clone SK1, BD Biosciences), CD45RO-PECy7
(clone UCHL-1, BD Biosciences), CD45RA-APCy7 (clone
4KB5, Santa Cruz Biotechnology), IFNc-FITC (clone 25723.11,
BD Biosciences), MIP-1b-PE (clone D21-1351, BD Biosciences),
CD107a-APC (clone H4A3, BD Biosciences), CD127-Alexa647
(clone HIL-7R-M21, BD Biosciences), IL-2-PE (clone 5344.111,
BD Biosciences), TNF-a-PB (clone MAb11, BioLegend). Aqua
Viability Dye (Molecular Probes/Invitrogen) was added to
distinguish live and dead cells. PBMC from four wells were
combined and 150,000 events were acquired for each analysis
using an LSRII flow cytometer (BD Biosciences) with FACSDiva
software (BD Biosciences). We developed software, which will be
referred to as ‘‘Clust’’, that performed semi-automated sequential
gating to identify cell subsets of interest (Fig. S4 and Text S1). In
brief, Clust uses both cluster analysis and filtering strategies with
rectangular filters to select positive cell subsets. The first three
gating steps all use cluster analysis to subsequently define live cells,
T cells, and CD3
+CD4
+ or CD3
+CD8
+ cell populations,
respectively. To identify cell subsets positive for the functional
markers IFN-c, MIP-1b and CD107a, we used a filtering strategy
where the filter was rectangular and had fixed coordinates in the
different channels. The gating procedure included a normalization
step in which the lower filter coordinates were adjusted to the cell
distribution in the non-stimulated control sample.
Data Analysis and Statistical Methods
We assumed that the data was not normally distributed and
used Wilcoxon’s rank sum test, or for paired data, Wilcoxon’s
signed rank test, to identify significant differences (P,0.05)
between data sets. To test whether two data sets showed the
same trend and whether they were correlated we used Spearman’s
rank correlation test. A correlation with a coefficient (RS) above
0.4 was considered high, and a coefficient above 0.7 was
considered to indicate very strong correlation. To analyze the
antigen-dependent increase in CMI responses, differences were
calculated by subtracting the response to a low antigen
concentration from the response to a high antigen concentration.
Group-wise comparison between donor groups was performed
using Wilcoxon’s rank sum test. Logistic regression, using log-
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modeling. Missing values in the LPA, secreted cytokines, or
integrated median fluorescence intensity (iMFI) data, which
occurred mainly in the naı ¨ve donor group due to values below
the detection limit, were imputed by repeated random sampling
from non-missing values for the same donor group. In total, the
analyses were based on 32 individuals; 11 vaccinees, 12 patients,
and 9 naı ¨ve donors. To reduce the complexity of modeling, iMFI
values of functional markers in bi- or trifunctional cell subsets, e.g.
iMFI of IFNc and MIP1b in IFN-c
+MIP-1b
+CD45RO
+CD4
+
cells, were joined into one parameter by taking the first
standardized principal component for these measures. Model
selection was applied using ‘‘leave one out’’-cross validation with
the complexity of the model as selection criteria. Only models with
one or two variables were considered; models with one variable
were based on equation 1, those with two variables on equation 2.
equation 1 : P~
1
1ze
{ b0zb1X1 ðÞ
equation 2 : P~
1
1ze
{ b0zb1X1zb2X2zb3X1 X2 ðÞ
b0 is the intercept and bi are the coefficents for the model. If no
interaction is specified, b3 is 0 in equation 2.
Selection of the variables was done in two steps. First, we
estimated the predictive power of each individual variable.
Features with a predictive power .0.9 were excluded from
further modeling. Second, we estimated the predictive power of
combinations of two of the remaining variables, with and without
an interaction term. Additive (‘‘+’’ in Table 1) or synergistic (‘‘x’’
in Table 1) interaction was considered significant if it increased
the predictive power with .0.03. The predictive power of the final
model was estimated using ‘‘leave one out’’-cross validation.
Supporting Information
Figure S1 Frequency of IL-2
+ (upper graphs) or TNF-a
+
(lower graphs) T cells and CD4
+ (left graphs) or CD8
+
(right graphs) T cells after stimulation with graded
antigen concentrations. Median values 6 SEM are shown for
1–5 naı ¨ve individuals (white bars) or 7–11 LVS vaccinees (black
bars).
(TIF)
Figure S2 Frequency of CD3
+CD4
+CD8
+ or CD3
+CD4
2
CD8
2 T cells after stimulation with graded antigen
concentrations. A, Percentage of CD4
+CD8
+ cells of the total
CD3
+ lymphocyte population. B–D, Percentage of CD4
+CD8
+
(black bars) or CD4
2CD8
2 T cells (white bars) that express at
least one intracellular marker, IFN-c, CD107a, or MIP-1b,
respectively. The bars indicate (from left to right) antigen
concentrations of 0, 0.02, 0.1, and 0.05 ffLVS/PBMC. Mean
values per donor group are shown.
(TIF)
Figure S3 Hierarchical cluster analysis of iMFI values
of intracellular markers in CD3
+CD4
+ or CD3
+CD8
+ T-
cell subsets in response to 0.1 cfu ffLVS/PBMC. Inte-
grated MFI values were obtained for all three functional
markers (IFN-c, MIP-1b, CD107a) in all mono- and
bifunctional T-cell subsets (18 values per PBMC sample)
and for all donors using Clust semi-automated gating.
Trifunctional cell subsets were excluded from this analysis since
there were few such cells. For the multivariate analysis log-
transformed and standardized data were used together with
Manhattan distance and Ward’s method and the results presented
as a dendrogram. Each symbol marks a different donor.
(TIF)
Figure S4 Flow cytometry gating strategy. Live cells
were gated from total events by use of Viability Dye
staining. From live cells, lymphocytes were gated based on
morphology detected as forward and side scatter, FSC and SSC.
CD4
+ T cells were gated as CD3
+CD4
+ and CD8
+ T cells as
CD3
+CD8
+. CD4
+ and CD8
+ populations were further gated in
separate plots with CD45RO
+ or MIP-1b on the y-axis and IFN-c
on the x-axis. Trifunctional cells, i.e. memory cells expressing IFN-
c, MIP-1b, and CD107a, were obtained by gating CD107a
+ and
MIP-1b
+ cells from IFN-c
+CD45RO
+ subsets.
(TIF)
Table S1 Probability values for the comparison of
proliferative responses to ffLVS by PBMC from naı ¨ve
individuals (nv), vaccinees (vc) and patients (p).
(DOCX)
Table S2 Probability values for the comparison of the
antigen-dependent increase (0–0.1 cfu ffLVS/PBMC) in
cytokine levels secreted by PBMC from naı ¨ve individu-
als (nv, 11–13 donors), vaccinees (vc, 11–15 donors) or
patients (p, 14–15 donors).
(DOCX)
Tables S3A–S3F Parameters for Clust semi-automated
gating. Table S3A: Parameters for logicle transformation.
Table S3B: Parameters for ‘tmixFilter’ object for clustering live
cells. Table S3C: Parameters for ‘tmixFilter’ object for clustering
CD3
+ cells. Table S3D: Parameters for ‘tmixFilter’ object for
clustering CD3
+CD4
+. Table S3E: Parameters for ‘tmixFilter’
object for clustering CD3
+CD8
+. Table S3F: Lower and upper
boundaries for gating multifunctional populations.
(DOCX)
Text S1 Description of the semi-automated gating
method.
(DOCX)
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